1Hesketh P J.Comparative review of 5-HT3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting[J].Cancer Invest,2000,18(2):163.
2Coates A,Abraham S,Kaye S B,et al.On the receiving end-patient perception of the side-effects of cancer chemotherapy[J].Eur J Cancer Clin Oncol,1983,19(2):203.
3Dewan P,Singhal S,Harit D.Management of chemotherapy-induced nausea and vomiting[J].Indian Pediatr,2010,47(2):149.
4Navari R M.Pathogenesis based treatment of chemotherapy induced nausea and vomiting two new agents[J].J Support Oncol,2003,1(2):89.
5Bloechl-Daum B,Deuson R R,Mavros P,et al.Delayed nausea and vomiting continue to reduce patients′ quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment[J].J Clin Oncol,2006,24(27):4472.
6Kaiser R,Sezer O,Papies A,et al.Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes[J].J Clin Oncol,2002,20(12):2805.
7Grunberg S M,Dugan M,Muss H,et al.Effectiveness of a single-day three-drug regimen of dexamethasone,palonosetron,and aprepitant for the prevention of acute and delayed nausea and vomiting caused by moderately emetogenic chemotherapy[J].Support Care Cancer,2009,17(5):589.
8Rojas C,Thomas A G,Alt J,et al.Palonosetron triggers 5-HT(3) receptor internalization and causes prolonged inhibition of receptor function[J].Eur J Pharmacol,2010,626(2-3):193.
9Gralla R,Lichinitser M,Van Der Vegt S,et al.Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy:Results of a double-blind randomized phase Ⅲ trial comparing single doses of palonosetron with ondansetron[J].Ann Oncol,2003,14(10):1570.
10Navari R M.Pathogenesis-based treatment of chemotherapy-induced nausea vomiting-two new agents[J].J Support Oncol,2003,1(2):89.
二级参考文献7
1Hesketh PJ.Comparative review of 5-HT3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting[J].Cancer Invest,2000,18:163-173.
2Geling O,Eichler HG.Should 5-hydroxytryptamine-3 receptor antagonists be administered beyond 24 hours after chemotherapy to prevent delayed emesis? systematic re-evaluation of clinical evidence and drug cost implications[J].J Clin Oncol,2005,23(6):1289-1294.
3Gralla R,Lichinitser M,Vegt SV,et al.Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy:results of a double-blind randomized phase Ⅲ trial comparing single doses of palonosetron with ondansetron[J].Ann of Oncol,2003,14(10):1570-1577.
4Eisenberg P,Figueroa-Vadillo J,Zamora R,et al.Improved prevention of moderately emeto-genic chemotherapy-induced nausea and vomiting with palonosetron,a pharmacologically novel 5-HT3 receptor antagonist:results of a phase Ⅲ,single-dose trial versus dolasetron[J].Cancer,2003,98(11):2473-2482.
5Piraccini G,Stolz R,Tei M,et al.Pharmacokinetic features of a novel 5-HT3-receptor antagonist:palonosetron (RS 25259-197)[J].Proc Am Soc Clin Oncol,2001; 20:400a (Abstr 1595).
6Oge A,Alkis N,Oge O,et al.Comparison of granisetron,ondansetron and tropisetron for control of vomiting and nausea induced by cisplatin[J].J Chemother,2000,12:105-108.
7Hickok JT,Roscoe JA,Morrow GR,et al.5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin:a URCC CCOP randomised controlled trial[J].Lancet Oncol,2005,6(10):765-772.
5Roila F, Hesketh P J, Herrstedt J, et al. Prevention of chemotherapy and radio therapy induced emesis: resultsof the 2004 Perugia International Antiemetic Consensus Con- ference[J]. Ann Oneol, 2006, 17(1): 20.
6Thongprasert S. Efficacy and tolerability Of tropisetron in the prevention of cisplatin - induced nausea and vomiting in ad- vanced non-small cell lung caneer[J]. Acta 0ncol, 2000, 39(2): 221.
7Gralla R, Lichinitser M, van Der vegt S, et al. Palonosetron improves prevention of chemotherapy- induced nausea and vomiting following moderately emetogenic chemotherapy: re- sults of a double - blind randomized phase 111 trial comparing single doses of palonosetmn with ondansetron[J ]. Ann On- col, 2003, 14(10): 1570.
8Aapm M S, Bertoli L, Lordick F, et al. Palonosetmn(PA- IX)) is effective in preventing acute and delayed chemotherapy - induced nausea and vomiting (CINV) in patients receiving highly emetngenic chemotherapy(HEC) [J]. Supportive Care in Cancer, 2003, 20(11): 391.
9周际昌.实用肿瘤手册[M].北京:人民卫生出版社,1999:480-481.
10Alvarez O, Freeman A, Bedros A,et al. Randomized double-blind crossover ondansetron-dexamethasone versus ondansetren-placebo study for the treatment of chemotherapy-induced nausea and vomiting in pediatric patients with malignancies [J]. J Pediatr Hematol Oncol,1995,17(2) :145-150.
